Pfizer's Geodon gets two new generic rivals; Job-cutting costs to weigh on Merck KGaA profits;

@FiercePharma: Roche reportedly tapped Emcure to make Herceptin (cancer) and Pegasys (hep B and C) for sale in India at a discount. More | Follow @FiercePharma

> Dr. Reddy's Laboratories and Lupin launched their versions of Pfizer's ($PFE) antipsychotic drug Geodon, which brought in more than $1.3 billion last year. Report | Report

> Merck KGaA expects slightly higher sales in 2012, but costs associated with job cuts will weigh on profits, the company said. Article

> Pfizer sued Johnson & Johnson's ($JNJ) consumer health unit, saying its Thermacare patents are infringed by McNeil's heat-releasing Precise patch. Report

> HealthCanada is considering bringing in alternative drugs from overseas to combat new shortages. Report

> Boehringer Ingelheim plans to put 17 million euros into expanding its biopharma development and manufacturing capacity at two facilities in Germany and Austria. News

> Drug distributor AmerisourceBergen ($ABC) will pay $520 million for World Courier Group, which provides transport and logistics services to the pharma and biotech businesses. Report

> Germany's healthcare company Fresenius was asked to write down the Greek bonds it accepted as payment for past-due hospital bills, and other healthcare companies are expected to follow. Article

> A U.S. appeals court blocked the Drug Enforcement Administration's suspension of a Cardinal Health distribution facility, pending court filings due mid-month. Story

Biotech News

@FierceBiotech: Aragon Pharmaceuticals raises $42M for closely watched prostate #cancer drug. Article | Follow @FierceBiotech

@JohnCFierce: FierceMedicalDevices tracked the top VC device deals of H2 2011. Report | Follow @JohnCFierce

@MarkHFierce: Roche to Illumina: "You're not the only game in in town." In other words, the pressure mounts. Reuters Story | Follow @MarkHFierce

> Domain partners with RusNano on $760M biotech investment plan. News

> Aegerion application for lead rare disease drug lands at FDA. Story

> Abcam's $155M Epitomics buyout expands antibody business. Article

> Oncothyreon shares routed as Stimuvax PhIII trial soldiers on. More

Research News

> UCLA's 'molecular tweezers' dismantles Parkinson's in zebra fish. More

> Canadian cancer funding targets radical projects. Item

> Breakthrough IDs possible liver repair process. Story

Manufacturing News

> FDA cites Gulf Pharmaceutical for predating documentation. News

> Novartis names new leader for its troubled OTC operations. Story

> India's Emcure to manufacture Roche's Herceptin, MabThera. Article

And Finally... How many people have experienced statin-related brain fog? Hard to tell. Report